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Objectives: Neonates born extremely prematurely are at high risk of
acute and prolonged pain. Effective treatment requires reliable pain
assessment, which is currently missing. Our study explored whether
existing pain assessment tools and physiological indicators measure
pain and comfort accurately in this population.
Materials and Methods: We prospectively collected data in 16
neonates born at less than 29 weeks’ gestational age during 3 con-
ditions: skin-to-skin care, rest, and heelstick procedure for capillary
blood sampling in the incubator. The neonates were video recorded
in these situations, and recordings were coded using 5 observational
pain assessment tools and numeric rating scales for pain and dis-
tress. We simultaneously collected heart rate, respiratory rate,
arterial oxygen saturation, regional cerebral oxygenation, and the
number of skin conductance peaks. All measures across the 3 con-
ditions were compared using general linear modeling.
Results: The median gestational age was 27.1 weeks (range: 24.1 to
28.7). Forty measurement periods across the 3 conditions were
analyzed. Heart rate was significantly higher during heelstick pro-
cedures compared with during rest, with a mean difference of 10.7
beats/min (95% confidence interval [CI]: 2.7-18.6). Oxygen satu-
ration was significantly higher during skin-to-skin care compared
with during heelstick procedures with a mean difference of 5.5%
(95% CI: 0.2-10.8). The Premature Infant Pain Profile-revised
(PIPP-R) score was significantly higher during heelstick procedures
compared with skin-to-skin care with a mean difference of 3.2
points (95% CI: 1.6-5.0).
Discussion: Pain measurement in clinical practice in prematurely
born infants below 29 weeks remains challenging. The included
behavioral and physiological indicators did not adequately dis-
tinguish between a painful situation, rest, and skin-to-skin care in
premature neonates.
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I n a European Delphi study published in 2015, “pain andstress” were considered the most important research pri-
ority for all neonates in Neonatal Intensive Care Unit
(NICU) nursing.1 Previous research showed that the number
of painful interventions (causing mucosal or skin injury) that
NICU patients experience during their first 14 days of life is
the highest for the most premature neonates (24 to 29 wk),
namely 14 per day compared with 10 for neonates of 30 to
32 weeks and 9 for those between 33 and 36 weeks.2 Fur-
thermore, neonates born extremely prematurely are at the
highest risk of painful conditions, such as necrotizing
enterocolitis3 and potentially painful and stressful mech-
anical ventilation.2 Nonetheless, pain responses of these
vulnerable infants are still poorly understood.4
Because we started to treat neonates born extremely
prematurely at many NICUs, it is our duty to protect them
from pain and distress just as well as older patients. Expe-
riencing pain is associated with poor growth,5 impaired
brain development,6 altered corticospinal development,7
and reduced school-age visual perceptual abilities in these
infants.8 To mitigate the effects of pain effectively, we must
ensure that we can accurately assess pain in these patients.
Various validated pain assessment tools are available
for use in the neonatal intensive care unit, for example, the
Premature Infant Pain Profile Revised (PIPP-R) and Neo-
natal Infant Pain Scale (NIPS) for acute pain, and the
COMFORTneo scale and Neonatal Pain, Agitation, and
Sedation Scale (N-PASS) for more prolonged pain.9–12
A review by Cong et al13 shows that none of the published
neonatal pain assessment tools was validated in neonates
with a gestational age younger than 29 weeks. The tools
partially (multidimensional scales) or fully (unidimensional
scales) rely on behavioral cues, which may be difficult to
assess in very premature neonates. Many pain scales rely
heavily on facial indices, although very premature infants
show less vigorous facial response than do neonates with
higher gestational age at birth, as their neuromuscular sys-
tem is still developing.4 Moreover, health care professionals
find the responses short-lasting and unpredictable.4
Physiologically based tools may be an alternative to
behavioral pain assessment. For example, skin conductance
(SC) measurement seems promising to assess acute pain in
premature neonates with a gestational age between 22 and
27 weeks.14 Studies measuring cerebral oxygen saturation
using near infrared spectroscopy (NIRS) in preterm infants
from 25 weeks’ gestational age showed that noxious stimuli
caused by a heelstick or venipuncture were transmitted to
the cortex.15,16 Vital signs such as heart rate (HR) increase
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in response to acute pain,17 although the increases may also
be the result of other physiologic factors, such as
hypovolemia.
At this time, there are no tools validated for assessing
pain specifically in premature neonates <29 weeks. As these
infants may react differently to pain than do more mature
neonates,4 we hypothesized that existing pain measurement
tools, both behaviorally and physiologically based, might be
less valid to evaluate pain and comfort in a very premature
patient. The aim of this observational study was to test the
above hypothesis.
MATERIALS AND METHODS
Study Design
This was a prospective, observational, exploratory study.
Patients and Setting
This study was conducted from September 2015 to June
2016 in the level 4 neonatal intensive care unit of the Erasmus
MC—Sophia, Rotterdam, the Netherlands. Premature infants
born with a gestational age below 29 weeks were eligible for
inclusion, and neonates were selected by convenience sam-
pling. Infants expected to die within 48 hours after birth, and
those with severe intraventricular hemorrhage (grade 3 or
greater) and/or other neurological damage based on screening
cranial ultrasound, were excluded. Data were collected until a
postnatal age of 28 days or until discharge. The institutional
ethics review board waived the need for approval (MEC-2014-
324) because the study was judged to be an observational
study. However, parents were asked to provide written consent
for video-recording of their infants, for applying SC electrodes,
and for using the NIRS and vital signs data collected as part of
the standard of care. We refrained from performing a power
analysis, as this was the first study on pain assessment
parameters in extremely preterm infants, and no data on
variability of parameters were available.
Assessment Tools
 Behavioral pain observation tools:
 PIPP-R: This is a 7-item scale including behavioral state,
gestational age, change in HR, change in peripheral
oxygen saturation, and 3 items for facial expression. Items
are scored 0 to 3, and the total score range is 0 to 21.
Three points are added for neonates with a gestational age
below 28 weeks and 2 points if gestational age is between
28 and 32 weeks. A score <7 is taken to indicate no or
minimal pain.9
 NIPS: This includes 6 items, namely facial expression,
crying, breathing pattern, arms, legs, and state of arousal.
Items are scored 0 to 1 or 2, and the total score range is
0 to 7. A score of 2 or less is taken to indicate adequate
pain treatment.11
 Behavioral Indicators of Infant Pain (BIIP): This
includes the assessment of behavioral state, 5 facial
expressions, and 2 hand movements. Items are scored
0 to 1 or 2, and the total score range is 0 to 9.18 Scores
between 3 and 6 and between 7 and 9 are taken to
indicate, respectively, moderate and severe pain.
 COMFORTneo: This includes 6 items, namely alertness,
calmness/agitation, crying (nonventilated infants), respi-
ratory response (ventilated infants), body movements,
muscle tone, and facial tension. Each item has a score
range of 1 to 5, and the total score range is 6 to 30.
A score of 14 and higher is considered a sign of distress
and pain.12
 Neonatal Pain, Agitation and Sedation Scale (N-PASS):
This is a 5-item scale including crying/irritability, behavior
state, facial expression, extremities tone, and vital signs.
Each item is scored from 0 to 2; thus, the total score
ranges from 0 (no pain) to 10 (pain/agitation). The same
correction for gestational age is applied as for the PIPP-R.
The goal of pain treatment is a score of 3 or less.10
 Numeric Rating Scale (NRS) pain and distress scores:
NRS scores range from 0 to 10 with cut-off scores set
at ≥ 4 for both NRS pain and NRS distress.
 Physiological parameters: Data on HR, respiratory rate,
and oxygen saturation (SpO2) were collected automati-
cally from bedside monitors (Infinity M540, Drägerwerk
AG & Co. KGaA, Lübeck, Germany).
 Regional cerebral oxygenation: regional cerebral oxygen
saturation (crSO2) was measured with NIRS (NIRS via
INVOS 5100C, Somanetics Corporation, USA). As per our
NICU standard of care, one neonatal NIRS electrode was
placed on the frontolateral aspect of the head, either left or
right, depending on the infant’s position. This placement site
was chosen to minimize the number of interventions related
to this study.
 Skin conductance: A SC monitor (MED-storm Innova-
tion AS, Oslo, Norway) was connected to 3 electrodes
placed on the foot.
Procedures
As part of the standard of care, preterm infants at the
NICU often undergo a heelstick procedure, which is painful,
and, on the other hand, receive skin-to-skin care, an
intervention considered to bring comfort or even pain
relief.19 For a pain measurement indicator to be suitable for
extremely premature infants, we would expect scores to be
significantly different painful and comforting procedures.
Therefore, we chose the following conditions to deter-
mine whether indicators were able to discriminate between
conditions of pain, rest, and comfort:
 Skin-to-skin care (comfortable): The infant was placed on the
mother’s or father’s chest lying skin-to-skin, after which the
NIRS and SC electrodes were reconnected. The infant was
not disturbed during skin-to-skin care.
Measurement period: This lasted 2 minutes, from the
start of video registration and the moment when clear
signals for data collection from the NIRS and SC
measurements were received.
 At rest (baseline): with the infant positioned in a nest and
covered by a blanket, data collection started after no
interventions had been applied for at least 30 minutes.
Measurement period: This lasted 2 minutes starting at
least 30 minutes after any handling of the neonate.
 Heelstick procedure (painful): By protocol, each infant
received 0.5 ml sucrose 2 minutes before a heelstick
procedure. Facilitated tucking was applied from the
administration of sucrose until the end of the procedure
by a health care assistant, nurse, or parent.
Measurement period: From the moment the heel was
punctured until the band-aid had been applied to
the heel.
We considered the 2-minute measurement period for
skin-to-skin care sufficient to observe a reaction to the
stimulus. If clinically possible, the measurements under the
different conditions took place on the same day. During
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data collection, the full-body was filmed using one camera
(Sony HDR-PJ810E). SC electrodes were placed, if possible,
on the foot that was not to be punctured. Correct placement
of the NIRS electrode on the frontolateral aspect of the head
was checked before starting the measurement.
Data Extraction
Immediately before video recording, the exact time
displayed on the monitors collecting data on vital parameters,
crSO2, and SC was filmed for each condition. This was to
synchronize these data with the corresponding video
sequences.
 Behavioral pain observation tools: For each condition, the
research nurse (N.J.M.) applied the 5 validated pain assess-
ment tools described above and the NRS for pain and the
NRS for distress. Each video segment was viewed in real-time
and lasted 2 minutes; for condition 3 (heelstick), these
2 minutes followed the puncturing of the heel. With regard to
the PIPP-R, for which a shorter, 30-second observation
period is prescribed, the indicated amounts of time used for
the classification of the items for facial expressions were
multiplied by 4 (4×30 s). N.J.M. applied the following scoring
strategy after having viewed a 2-minute video fragment. For
instance, first, all items related to facial expression from all the
scales were consecutively scored and so on for the other items.
If necessary, the video segment was viewed multiple times
until all items of the 5 pain assessment instruments were
scored. Total pain assessment scores were calculated, and a
correction was applied if one or more of the items could not
be assessed (eg, a score was multiplied by 7/6 if one of 7 items
could not be observed). We adjusted for missing items
because we considered it unjustified to completely ignore these
scores. N.J.M. could not be blinded to the different conditions
because
these were clearly recognizable. Before start of the study, the
interrater reliability of N.J.M. was determined for the PIPP-R
and COMFORTneo scale. Linearly weighted κ of N.J.M.
compared with a trained neonatologist (for PIPP-R) and
MvD (for COMFORTneo) was 0.85 and 0.92, respectively.
 Physiological parameters and crSO2: These values were
extracted once per second during the measurement period,
and mean and SD of each patient’s measurements were
calculated for each parameter. These values had also been
extracted during the 2 minutes immediately before the
conditionmeasurement period; the mean value was calculated.
The change between the mean value of this baseline period
and that of the measurement period was determined.
 Skin conductance: The mean number of SC peaks
per second (sc peaks/s) during the measurement period
and the change in the number of peaks per second
compared with that in the 2 minutes immediately before
this period was calculated using the Med-Storm software
with a preset threshold value of 0.005 micro Siemens. A
higher number of SC peaks suggests more pain.20
Data Analysis
Infant characteristics and other data are presented as
median (interquartile range) for continuous variables and as
percentages for categorical variables. General linear mod-
eling, which is a generalization of linear regression analysis
to account for repeated measurements, was applied to
compare the previously described assessment tools between
the 3 different conditions. The independent variables were
condition (pain, rest, or comfort) and postnatal age in days
(coded as a continuous variable); the dependent variable
was the pain indicator.
An unstructured error covariance matrix was assumed
in the general linear models to account for the within-subject
correlations. Dependent variables that were not normally
distributed were transformed using the square root or the
natural logarithm of the data for the general linear model.
SPSS 21.0 was used for all analyses, and all statistical tests
used a 2-sided significance level of 0.05.
RESULTS
Patient Characteristics
Sixteen neonates were included, whose median gesta-
tional age was 27 weeks and 1 day (range: 24.1 to 28.7 wk;
see Table 1 for background characteristics). The median
postnatal age at the time of assessment was 17 days (inter-
quartile range: 14 to 23 d). Eleven neonates were assessed in
all conditions on the same day, the other 5 at intervals from
2 to 17 days. If both skin-to-skin care and the heelstick
procedure were assessed on the same day, the time interval
between these 2 events was at least 3 hours. None of the
patients received any analgesics or sedatives other than
sucrose during the observation days.
Physiological and Behavioral Indicators
Table 2 shows the main outcomes during the 3 different
conditions. A total of 40 observations were included; 6 skin-
to-skin care sessions had been missed for logistic reasons;
one neonate did not require a heelstick procedure and one
other had been disturbed at least every 30 minutes during
the observation days. Physiological parameters for some
observations were lacking because of technical difficulties
(Table 2).
The results of the general linear modeling are shown in
Table 3. Significant differences between the different con-
ditions were found for the HR, SpO2, and the PIPP-R. The
mean HR was significantly higher during a heelstick pro-
cedure compared with rest (estimate 10.7, 95% confidence
interval [CI]: 2.7-18.6, P= 0.01), but not compared with
skin-to-skin care (5.5, 95% CI: −1.7 to 12.8, P= 0.12). The
HR varied greatly between patients and during the 3 con-
ditions (Fig. 1). The change in HR from baseline was
TABLE 1. Patient and Measurement Characteristics
Variables N Median IQR
Patient characteristics (N= 16)
Boy/Girl 12/4
Gestational age (wk) 27.1 25.7-28.0
Birth weight (g) 938 865-1261
Measurement characteristics (N= 40)
Postnatal age (d) 17 14-23
Time between observation days per
patient (d)*
0 0-7
Ventilatory support
Invasive ventilation
Endotracheal tube 6
Noninvasive ventilation
Nasopharyngeal tube 19
Silicone double nasal tube (Vygon) 5
Nasal cannula Optiflow 10
*The number of days between the observations of the different
conditions.
IQR indicates interquartile range.
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significantly greater during the heelstick procedure than
during both skin-to-skin care (estimate 8.8, 95% CI: 5.9-
11.8, P< 0.001) and rest (8.4, 95% CI: 6.0-10.8, P< 0.001)
(Fig. 2). Moreover, both the mean oxygen saturation (esti-
mate 5.5, 95% CI: 0.2-10.8; P= 0.04) and the change in
oxygen saturation from baseline (4.5, 95% CI: 0.8-8.3; P=0.02)
were significantly higher during skin-to-skin care than during the
heelstick procedure, while this difference was not significant when
comparing rest with the heelstick procedure.
Observational Pain Assessment
General linear modeling was not possible for the NRS
pain because 80% of the scores were 0. A significant dif-
ference between conditions was only found for the PIPP-R
score. This score was on average 3.2 points lower during
skin-to-skin care than during the heelstick procedure (95%
CI: −5.0 to −1.6, P= 0.002). The PIPP-R scores varied
greatly between patients (Fig. 3). For example, while the
PIPP-R score during heelstick procedure was higher than
during rest for 7 patients, the reverse was true for the 6 other
patients. Because general linear modeling was already
applied to compare the vital signs, the analysis of the PIPP-
R and N-PASS scores was repeated after the exclusion of
the item(s) related to vital signs. The PIPP-R during skin-to-
skin care remained significantly lower than during the
heelstick procedure (−2.0, 95% CI: −3.1 to −0.9, P= 0.03),
while the differences in PIPP-R score between rest and the
heelstick procedure and the differences in N-PASS scores
remained statistically insignificant.
Practical issues had prevented scoring a number of
items of the 5 different scales. For 86 (43%) of the 200 pain
scores, all items could be assessed; all other scores had to be
recalculated. Striking examples are muscle tension of the
legs (NIPS) and nasolabial furrow (PIPP-R, BIIP), which
could not be assessed in, respectively, 36 (90%) and 32 (80%)
of the 40 observations. One infant appeared to be fully
covered by the 2 hands of the caregiver and a blanket during the
heelstick procedure, making it impossible to score any item.
DISCUSSION
We found that pain measurement in extremely preterm
infants is challenging. In the total population studied, the
mean HR, SpO2, and PIPP-R each significantly differed
between a painful procedure and either rest or skin-to-skin
care. The change in HR from baseline was the only
parameter that was significantly different between all three
conditions. Although these studied indicators seem to be
most promising to assess pain, their applicability in clinical
practice is complicated by the large variability in pain
expression of this specific population.
The heelstick procedure is a painful procedure, which is
often used in validation studies. A valid tool is preferably
also responsive, that is, it should yield a higher score during
the heelstick procedure compared with rest or skin-to-skin
care. In our study population, the difference in scores
between the 3 studied conditions was only statistically sig-
nificant for the PIPP-R. It is unclear why the other pain
scores could not discriminate between the different sit-
uations. A possible reason is the extreme prematurity of the
study population. Pain processing in premature infants is
still developing; in a previous study, infants with the
youngest gestational age showed the least change in facial
behavior during a heelstick procedure.21 A recent study by
Green et al22 demonstrated that neonates were able to show
discriminative facial expressions to tactile and noxious
stimulation only from ~33 weeks’ gestation. The validation
studies of the included instruments also included neonates
TABLE 2. Physiological and Behavioral Parameters
Skin-to-Skin Care (N= 10) Rest (N= 15) Heelstick (N= 15)
N Median IQR N Median IQR N Median IQR
Physiological parameters
SK peaks/s 10 0.18 0.06-0.76 15 0.09 0.00-0.33 15 0.22 0.03-0.34
Heart rate*
Mean 8 163 156-169 14 158 150-169 13 166 152-175
SD 2.2 2.0-5.5 1.8 1.6-2.9 3.1 2.6-3.7
Respiratory rate*
Mean 8 39 31-50 14 50 38-62 13 48 34-59
SD 16.8 10.1-19.5 12.5 8.7-15.9 9.3 7.6-17.3
SpO2*
Mean 8 93 91-95 14 95 91-98 12 91 86-97
SD 1.2 0.8-1.3 0.8 0.6-2.2 1.8 1.0-4.6
crSO2*
Mean 9 63 55-67 15 64 56-69 15 61 50-66
SD 1.4 0.9-2.7 1.4 1.0-2.9 1.4 1.1-2.9
Pain assessment tools
COMFORTneo 10 12 9-15 15 11 8-16 14 12 11-13
N-PASS 10 3 2-4 15 3 2-4 14 3 3-5
NIPS 10 1 0-3 15 0 0-4 14 1 0-3
PIPP-R 10 6 4-7 15 8 7-9 14 8 8-12
BIIP 10 1 0-2 15 0 0-2 14 2 0-4
NRS pain 10 0 0-0 15 0 0-0 14 1 0-2
NRS distress 10 0 0-2 15 0 0-3 14 0 0-2
*For the physiological parameters heart rate, respiratory rate, SpO2, and crSO2, the mean and the SD of the data per second during the measurement period
were calculated for each patient separately.
BIIP indicates Behavioral Indicators of Infant Pain; IQR, interquartile range; NIPS, Neonatal Infant Pain Scale; N-PASS, Neonatal Pain, Agitation and
Sedation Scale; NRS, Numeric Rating Scale; PIPP-R, Premature Infant Pain Profile-revised.
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TABLE 3. Estimated Effects (General Linear Model)
Skin-to-Skin Care (N= 10) Rest (N= 15)
Estimate 95% CI P Estimate 95% CI P Heelstick (N= 15)
Physiological parameters
SC peaks/s† 0.03 −0.26 to 0.31 0.84 −0.14 −0.32 to 0.04 0.13 Reference
Change −0.04 −0.14 to 0.07 0.49 −0.03 −0.15 to 0.10 0.64
Heart rate
Mean −5.54 −12.8 to 1.7 0.12 −10.69 −18.6 to −2.7 0.01*
Mean change −8.83 −11.8 to −5.9 < 0.001* −8.42 −10.8 to −6.0 < 0.001*
SD‡ −0.07 −0.05 to 0.38 0.75 −0.15 −0.57 to 0.27 0.46
Respiratory rate
Mean −4.42 −15.3 to 14.5 0.48 4.8 −7.9 to 17.5 0.43
Mean change 3.55 −5.6 to 12.7 0.42 −1.37 −13.0 to 10.3 0.80
SD 4.64 −1.56 to 10.84 0.13 1.22 −2.13 to 4.58 0.45
SpO2
Mean 5.48 0.2-10.8 0.04* 5.74 −0.6 to 12.1 0.07
Mean change 4.53 0.8-8.3 0.02* 3.43 −0.8 to 7.7 0.11
SD‡ −0.36 −0.79 to 0.06 0.09 −0.40 −0.91 to 0.10 0.11
crSO2
Mean 2.63 −3.8 to 9.0 0.39 3.53 −1.5 to 8.5 0.15
Mean change 3.26 0.1-6.5 0.05 1.70 −1.3 to 4.7 0.25
SD‡ −0.12 −0.41 to 0.17 0.38 −0.02 −0.30 to 0.26 0.89
Pain assessment tools
COMFORTneo −1.5 −3.9 to 1.0 0.21 −1.9 −4.5 to 0.6 0.13 Reference
N-PASS† −0.2 −0.6 to 0.1 0.17 −0.2 −0.5 to 0.1 0.22
NIPS‡ −0.3 −0.8 to 0.3 0.32 −0.2 −0.8 to 0.4 0.52
PIPP-R −3.2 −5.0 to −1.6 0.002* −1.0 −3.9 to 1.9 0.48
BIIP‡ 0.4 −1.0 to 0.1 0.13 −0.5 −1.1 to 0.1 0.10
NRS pain — — — — — —
NRS distress −0.4 −1.3 to 0.5 0.37 −0.3 −1.4 to 0.8 0.61
The model was adjusted for postnatal age for all outcomes.
For the physiological parameters heart rate, respiratory rate, SpO2, and crSO2, the mean and the SD of the second-to-second data during the measurement
period were calculated for each patient separately. Next to this, the difference between the mean value during and before the measurement period was calculated
and referred to as the “mean change.”
For skin conductance, the average number of peaks per second during the measurement period was calculated for each patient. After this, the difference
between this value and the average number of peaks per second during the baseline period was calculated and referred to as the “change.”
*< 0.05.
†Transformed using SQRT (variable).
‡Transformed using LN (variable+1).
BIIP indicates Behavioral Indicators of Infant Pain; CI, confidence interval; NIPS, Neonatal Infant Pain Scale; N-PASS, Neonatal Pain, Agitation and
Sedation Scale; NRS, Numeric Rating Scale; PIPP-R, Premature Infant Pain Profile-revised.
FIGURE 1. Mean heart rate during different conditions.
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older than 29 weeks.9–12,23,24 Holsti et al25 have found that
more specifically defined extremity movements are increased
in preterm infants at lower gestational ages. The BIIP does
include such movements, but other indicators may be
required for this population. As regards the N-PASS,
Munsters et al14 also did not find a significantly higher pain
score during the heelstick procedure compared with baseline
in a study among preterm infants with a gestational age
younger than 28 weeks. In that study, the SC during a
heelstick procedure was significantly higher than that at
baseline, suggesting more pain.14 We could not duplicate
these findings.
HR and SpO2 are considered the most sensitive bed-
side-available physiological variables to measure pain in
preterm and full-term infants.17 The same seems to hold true
in our study population. In our study, HR was significantly
lower only during rest compared with during the heelstick
procedure, with a mean difference of 11 beats/min. The
change in HR compared with a baseline period shortly
before the measurement period was significantly smaller
during skin-to-skin care and during rest than during the
heelstick procedure. In a previous study in extremely pre-
mature babies (below 28 wk), Gibbins et al26 found similar
HR responses during diaper change compared with the
heelstick procedure. The change in HR might not be specific
for pain, but related to increased stress as a result of the
diaper change and heelstick procedure. As in our study, in
that study, mean SpO2 did not statistically differ between a
heelstick procedure and baseline. However, in our study, the
mean SpO2 was significantly higher during skin-to-skin care
compared with during the painful situation. In their meta-
analysis, Boundy et al19 found significantly higher oxygen
saturations during skin-to-skin care compared with
conventional care.
We found no significant differences in cortical oxy-
genation measured with NIRS between the 3 studied con-
ditions, in contrast to a study by Slater et al.16 In that study,
however, the difference in total cerebral hemoglobin meas-
urement as an indicator for cerebral blood flow was meas-
ured before and after the heelstick procedure, whereas we
FIGURE 2. Mean heart rate compared with baseline during different conditions.
FIGURE 3. PIPP-R (Premature Infant Pain Profile—Revised) scores during different conditions.
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were only able to measure regional oxygen saturation, as we
used a different device (INVOS instead of NIRO-200).
Moreover, we measured oxygen saturation in the prefrontal
cortex instead of the somatosensory cortex in Slater’s study.
While both these brain areas are involved in pain process-
ing, the cortical responses in somatosensory and prefrontal
areas might vary in response to pain. Because measuring the
hemoglobin concentration in the somatosensory cortex
seems more promising, we would suggest further research to
focus on this aspect of the cerebral circulation.
One or more items of a scale could often not be scored
from the video footage. During rest, for example, fixation
material for the ventilator tubes and a blanket sometimes
blocked the view on the infant. The hands of the nurse pro-
viding facilitated tucking, and the pacifier complicated the
observation of facial expression during the heelstick procedure.
These limitations are inseparably linked to filming these vul-
nerable and very small premature infants without disturbing
the normal course of events. Munsters et al14 found observing
subtle changes in facial expression at the bedside in neonates
below 28 weeks’ gestational age difficult because of the pres-
ence of respiratory support, and oral and nasal gastric tubes.
The difficulty of observing neonatal facial expression during
current neonatology practices was the reason for Milesi et al27
to develop the “faceless” acute neonatal pain scale (FANS),
which does not rely on facial observation.
On the basis of our findings, we conclude that the
included pain indicators (except from the change in mean
HR from baseline) fail to detect different levels of both pain
and comfort in an individual very premature neonate.
However, during the observations of these infants under the
3 different conditions, we realized that this finding could
also be influenced by other factors than the altered pain
response of this specific population.
We expected the premature infants to be more com-
fortable on the mother’s or father’s chest compared with
lying in an incubator.19 However, we were not able to detect
this beneficial effect. In general, certain indicators may be
able to detect changes in pain intensity, but be not sensitive
to the level of comfort. Furthermore, we think that envi-
ronmental stressors such as noise and light might have
exerted an influence and that our open-bay unit resulted in a
greater exposure to stressors compared with a single-room
NICU.28 Another possible explanation for our finding could
be that some neonates had not yet calmed down after the
transfer from the incubator to the parent’s chest.4
It is also possible that the heelstick procedure was less
painful than we anticipated. Our protocol prescribes the use
of sucrose and facilitated tucking to minimalize heelstick-
related pain.29 Because of the convincing evidence on the
pain-related behavior effects of sucrose,30 we considered it
unethical to perform a heelstick procedure without the
administration of sucrose. However, the lack of change in
our measures is likely to be a result of the sucrose admin-
istration. Moreover, in view of the uncertainties with respect
to the working mechanisms of sucrose,31 and reported oxi-
dative stress32 and possible adverse effects on the brain,33,34
the American Academy of Pediatrics guidelines suggest that
more research is needed to establish long-term safety.29
The study design originally also included electro-
encephalography (EEG), but none of the neonates received
an EEG as part of their standard care. Recently, Hartley
et al35 validated an EEG-based measure of nociceptive brain
activity in healthy neonates with a gestational age above 34
weeks. Measuring brain activity using EEG in our study
population is complicated by, for example, the very thin and
vulnerable skin of the scalp.
Another pain indicator which we were unable to include
was HR variability, which can be analyzed using the Newborn
Infant Parasympathetic Evaluation (NIPE).36 While results
from previous studies using HR variability to assess prolonged
pain in both term and preterm neonates are promising,37,38
Cremillieux et al39 concluded that the NIPE index did not
appear to reliably measure acute procedural pain in preterm
infants. More research is needed to confirm the validity and
reliability to measure prolonged pain and comfort.
We were able to apply a combination of various
physiological and behavioral indicators during different
conditions in the same patient. It has been suggested that a
multimodal approach would help in the understanding and
management of infant pain.40,41
The small sample size of the present study may have
lowered the probability of finding significant differences
between the 3 conditions. However, we aimed to find pain
indicators that could be used in clinical practice, which
requires showing a relatively large difference between
painful and nonpainful circumstances. A larger sample
might have resulted in a higher number of significantly
different outcomes between the conditions. Yet, this would
not necessarily mean that these indicators would be clin-
ically relevant. We consider the large variation between the
different patients as the most important complicating factor
for using these indicators in clinical practice.
Our study is further limited by the fact that we wanted
to intervene as little as possible. Our NIRS-device only
measured oxygenation saturation in the prefrontal cortex,
and we were unable to include EEG registration.
We were also dependent on the interventions that were
clinically necessary during the observation day, and therefore
neonates postnatal ages at the time of the measurements were
not always the same. While we corrected for postnatal age in
the model, factors other than pain may have influenced
physiological indicators across the different circumstances. For
example, body temperature influences SC, and NIRS values
are positively correlated with postnatal age.15,42 In addition,
Grunau et al43 showed that higher cumulative neonatal pro-
cedural pain exposure was related to lower facial responses to
pain. The influences of these factors would be minimalized if
measurements took place on the same day.
In conclusion, of the potential physiological pain indica-
tors studied, only the change in HR was significantly different
between skin-to-skin care, rest, and heelstick procedure in these
extremely premature infants; none of the potential behavioral
pain indicators studied was. The HR, oxygen saturation, and
PIPP-R scores were most promising because they significantly
discriminated between at least 2 of the 3 conditions. However,
due to the large variation on these indicators between patients,
these are not readily applicable to discriminate pain from
comfort in an individual patient. Dampened responses to the
painful stimulus, vulnerability to environmental circumstances,
and practical issues seem to complicate pain measurement in
these children. For the time being, it seems that we still have a
long way to go before pain in neonates born prematurely can
be reliably measured.
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